FGFR3 targeting strategies for achondroplasia.

Expert reviews in molecular medicine

Volumn 14, Issue , 2012, Pages

  Laederich, Melanie B ^a   Horton, William A ^b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FGFR3 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; PROTEIN KINASE INHIBITOR;

ACHONDROPLASIA; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; MUTATION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ACHONDROPLASIA; ANTIBODIES; HUMANS; MOLECULAR TARGETED THERAPY; MUTATION; PROTEIN KINASE INHIBITORS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84866183996     PISSN: None     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/erm.2012.4     Document Type: Review

References (0)